Enabling Elucidation of the Biological Activity of Resveratrol Natural Products with Synthesis
通过合成阐明白藜芦醇天然产物的生物活性
基本信息
- 批准号:9219786
- 负责人:
- 金额:$ 27.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-01 至 2020-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAffinityAgingAnti-Inflammatory AgentsAnti-inflammatoryAntidiabetic DrugsAntioxidantsApoptoticArchitectureBeliefBindingBiologicalBiological ProcessBiological ProductsBiomimeticsCell Culture TechniquesCharacteristicsChemicalsChemistryCollaborationsCollectionCommunitiesComplexConsumptionCouplingDegenerative DisorderDevelopmentDimerizationElectronsEmployee StrikesEpidemiologyEvaluationFree RadicalsGene ExpressionGene Expression RegulationGenomicsHealthHealth BenefitHomeostasisHumanIn VitroIncidenceIndustryInvestigationKineticsLaboratoriesLettersLibrariesLife ExtensionLigandsLipid BilayersLongevityMeasurementMeasuresMethodologyMethodsMolecularMolecular ProbesNatural ProductsOrganic SynthesisOxidation-ReductionOxidative StressPaperPhenolsPhysiologicalPreparationPropertyProteinsReactive Oxygen SpeciesReportingResearchResponse ElementsResveratrolRoleRouteSeriesSignal TransductionSupplementationUniversitiesaqueousbasecellular targetingdimerepidemiology studyexperimental studyfood consumptionhigh throughput screeningindolineinhibitor/antagonistinterestlipid peroxidation inhibitoroxidationperhydroxyl radicalprofessorprophylacticquinone methidered winescreening
项目摘要
PROJECT SUMMARY
The current level of public interest concerning the health benefits of antioxidant supplements is
remarkable and is driven by the belief – on the basis of epidemiological evidence – that the
consumption of foods that are rich in antioxidants is associated with lower incidence of
degenerative disease and corresponding increase in longevity. Resveratrol is a particularly
striking example, and one where its biological activity and its oligomers has been a highly
contentious topic of debate for nearly 20 years. There is significant evidence that resveratrol has
anticancer, antidiabetic, and anti-inflammatory action, as well as life extension properties. The
mechanism of action for a simple molecule such as resveratrol is difficult to elucidate, since it is
a relatively promiscuous ligand that has low binding affinity towards its target proteins. As a
consequence of electron rich phenols, it is tempting to attribute many of these beneficial
properties to its ability to act as an antioxidant. Indeed, this association of antioxidant capacity
and its implications for human health has made radical quenching experiments ubiquitous in the
isolation papers of resveratrol based natural products. Despite extensive research within this
arena, there remains controversy over the benefits of antioxidants and their role in regulating
oxidative stress. In particular, there is a paucity of mechanistic understanding of the mode of
action of antioxidants and their metabolites at a molecular level. Accurate measurements of the
kinetics of ROS (reactive oxygen species) quenching by resveratrol are much more relevant to
understanding the role of resveratrol as an antioxidant and its biological activity. In fact, the
kinetics of this radical trapping by resveratrol suggest that it is highly unlikely that its primary role
is that of an antioxidant in a biological setting. In conjunction with the group of Professor Derek
Pratt (University of Ottawa), we will: (1) Develop cross-coupling methodologies using persistent
radicals for the synthesis of dihydrobenzofuran-containing resveratrol natural products
andbroadly evaluate the biological activity of these compounds; and (2) Determine the kinetics
of peroxyl radical-trapping of the compounds prepared in aim 1 in organic and aqueous solution,
lipid bilayers and cell culture; determine the anti-ferroptotic potential of good inhibitors of lipid
peroxidation and the anti-apoptotic potential of good inhibitors of cytosolic ROS formation;
determine the kinetics, mechanisms and products of resveratrol autoxidation under
physiologically-relevant conditions and extend these studies to resveratrol dimers/oligomers;
determine the electrophilic potential of resveratrol’s oxidative degradation products and carry
out experiments to identify their cellular targets; extend these studies to resveratrol
dimers/oligomers.
项目概要
目前公众对抗氧化剂补充剂的健康益处的兴趣程度是
值得注意的是,其驱动力是基于流行病学证据的信念:
食用富含抗氧化剂的食物与较低的发病率有关
白藜芦醇对退行性疾病和相应的寿命延长尤其有效。
一个引人注目的例子,其生物活性及其低聚物一直是高度关注的
近 20 年来一直争论不休的话题有重要证据表明白藜芦醇具有
抗癌、抗糖尿病和抗炎作用,以及延长寿命的特性。
白藜芦醇等简单分子的作用机制很难阐明,因为它是
相对混杂的配体,对其靶蛋白的结合亲和力较低。
富电子酚的结果,很容易将其中许多有益的归因于
事实上,这种抗氧化能力的关联。
及其对人类健康的影响使得激进的猝灭实验在世界各地无处不在
尽管对此进行了广泛的研究,但基于白藜芦醇的天然产品的分离论文。
关于抗氧化剂的益处及其在调节中的作用仍然存在争议
特别是,人们对氧化应激的机制缺乏了解。
在分子水平上准确测量抗氧化剂及其代谢物的作用。
白藜芦醇猝灭 ROS(活性氧)的动力学与
了解白藜芦醇作为抗氧化剂的作用及其生物活性。
白藜芦醇这种自由基捕获的动力学表明,它的主要作用不太可能是
是与德里克教授小组合作的生物环境中的抗氧化剂。
Pratt(渥太华大学),我们将:(1)使用持久性开发交叉耦合方法
自由基用于合成含二氢苯并呋喃的白藜芦醇天然产物
(2) 确定动力学
目标1中制备的化合物在有机溶液和水溶液中的过氧自由基捕获,
脂质双层和细胞培养;确定良好的脂质抑制剂的抗铁死亡潜力
细胞质 ROS 形成良好抑制剂的过氧化和抗凋亡潜力;
确定白藜芦醇自氧化的动力学、机制和产物
生理相关条件并将这些研究扩展到白藜芦醇二聚体/寡聚体;
测定白藜芦醇氧化降解产物的亲电势并携带
进行实验以确定其细胞靶标;将这些研究扩展到白藜芦醇;
二聚体/低聚物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Corey Stephenson其他文献
Corey Stephenson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Corey Stephenson', 18)}}的其他基金
Free radical strategies for bioactive molecule synthesis-Diversity Supplement
生物活性分子合成的自由基策略-多样性补充
- 批准号:
10671888 - 财政年份:2022
- 资助金额:
$ 27.11万 - 项目类别:
Free radical strategies for bioactive molecule synthesis
生物活性分子合成的自由基策略
- 批准号:
10330824 - 财政年份:2022
- 资助金额:
$ 27.11万 - 项目类别:
Free radical strategies for bioactive molecule synthesis
生物活性分子合成的自由基策略
- 批准号:
10534216 - 财政年份:2022
- 资助金额:
$ 27.11万 - 项目类别:
Free radical strategies for bioactive molecule synthesis - Undergraduate Supplement
生物活性分子合成的自由基策略 - 本科生补充材料
- 批准号:
10809306 - 财政年份:2022
- 资助金额:
$ 27.11万 - 项目类别:
Photoredox Catalysis Applications to Bioactive Compounds
光氧化还原催化在生物活性化合物中的应用
- 批准号:
8601711 - 财政年份:2011
- 资助金额:
$ 27.11万 - 项目类别:
Photoredox Catalysis Applications to Bioactive Compounds
光氧化还原催化在生物活性化合物中的应用
- 批准号:
8750909 - 财政年份:2011
- 资助金额:
$ 27.11万 - 项目类别:
Photoredox Catalysis Applications to Bioactive Compounds
光氧化还原催化在生物活性化合物中的应用
- 批准号:
8027011 - 财政年份:2011
- 资助金额:
$ 27.11万 - 项目类别:
Photoredox Catalysis Applications to Bioactive Compounds
光氧化还原催化在生物活性化合物中的应用
- 批准号:
8206535 - 财政年份:2011
- 资助金额:
$ 27.11万 - 项目类别:
相似国自然基金
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
面向免疫疗法标志物识别的基于多特征融合的肽与MHC亲和力预测研究
- 批准号:62302277
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向多场景应用的药物-靶标结合亲和力预测研究
- 批准号:62371403
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 27.11万 - 项目类别:
Anti-medin immunotherapy for vascular aging and related dementias
针对血管老化和相关痴呆的抗 Medin 免疫疗法
- 批准号:
10724869 - 财政年份:2023
- 资助金额:
$ 27.11万 - 项目类别:
Coordination of DNA Metabolism by Replication Protein A
复制蛋白 A 协调 DNA 代谢
- 批准号:
10623523 - 财政年份:2023
- 资助金额:
$ 27.11万 - 项目类别:
Targeting of RNA-binding protein FXR1 in HNSCC
HNSCC 中 RNA 结合蛋白 FXR1 的靶向
- 批准号:
10571379 - 财政年份:2023
- 资助金额:
$ 27.11万 - 项目类别:
Mineral Coated Microparticles for Stabilization and Delivery of Complexed mRNA for Healing of Long Bone Defects
用于稳定和递送复合 mRNA 的矿物涂层微粒,用于治疗长骨缺损
- 批准号:
10464358 - 财政年份:2023
- 资助金额:
$ 27.11万 - 项目类别: